<![CDATA[EU/3/17/1875 (Recombinant human interleukin-7 fused to a hybrid crystallisable fragment region of a human antibody) - NeoImmuneTech, INC., SpOlka Akcyjna, Oddzial w Polsce]]>

<![CDATA[EU/3/17/1875 (Recombinant human interleukin-7 fused to a hybrid crystallisable fragment region of a human antibody) - NeoImmuneTech, INC., SpOlka Akcyjna, Oddzial w Polsce]]> 1440 Copyright: (C) European Commission en-gb Tue, 23 May 2017 12:05:00 +0000 http://ec.europa.eu/health/documents/community-register/html/o1875.htm <![CDATA[EU/3/17/1875 (Recombinant human interleukin-7 fused to a hybrid crystallisable fragment region of a human antibody) - NeoImmuneTech, INC., SpOlka Akcyjna, Oddzial w Polsce]]> http://ec.europa.eu/health/documents/community-register/images/logo_en.gif http://ec.europa.eu/health/documents/community-register/html/o1875.htm 144 100 Orphan designation - Commission Decision (2017)3608 of Tue, 23 May 2017 New documents http://ec.europa.eu/health/documents/community-register/html/o1875.htm#proc137944 http://ec.europa.eu/health/documents/community-register/html/o1875.htm#proc137944 Tue, 23 May 2017 12:05:00 +0000